Help for Hide and Heart

Part of the misery of being diabetic is having to prick your finger or arm for glucose-level testing. And haste prevents waste when it comes to diagnosing a heart attack. Sandia researchers led by Jeb Flemming are developing diagnostic tools—ElectroNeedles and μPosts—that could benefit both diabetics and heart patients. Other members of the research team include Sandia's David Ingersoll and Carrie Schmidt, and Colin Buckley, a medical student at the University of New Mexico Medical School.

ElectroNeedles (photo, with needles in package center) are micron-sized electrodes capable of measuring glucose and other molecules that can either donate or accept electrons (redox behavior). Configured in arrays, the needles penetrate the skin painlessly and take a glucose measurement inside the body, without drawing blood. Rapid electrochemical analytical methods produce readings in seconds.

μPosts take advantage of optical technology to measure proteins and other macromolecules, including the elevated troponin I levels associated with certain types of heart attack. The procedure is painless, and the analytical results are available in <30 min. after the patient's arrival in the ER because most of the diagnostics can be handled in the ambulance en route. Compare this scenario with conventional diagnostic techniques that require drawing a blood sample and sending it to the lab, a protocol that can mean six hours of waiting.

Sponsored by Infosys

In Conversation with Antonio Neri, President & CEO – Hewlett Packard Enterprise & Salil Parekh, CEO – Infosys

Hear the CEOs of Infosys & HPE discuss the current crisis and how it has accelerated the need for digital transformation for their clients. Connectivity at the Edge, right mix of hybrid cloud, ability to extract data faster than ever before… these are just some of the contributions that HPE and Infosys make to our clients’ digital transformation journey.

The MicroNeedle and μPost platforms are mutually complementary. The tips of both devices are coated with a biologically active layer that measures concentrations of specific lipids, proteins, antibodies, toxins, viruses, and carbohydrates (e.g., glucose). Their size can be custom-tailored for different areas of the patient's skin—shorter for diabetes testing and longer for larger molecules in the blood such as troponin I.

Short Takes
Short Takes

The prototype ElectroNeedles and μPosts are fabricated of Foturan, a glass-like material. The market versions are expected to be made of an inexpensive, disposable plastic. Thus far they have been tested for measuring glucose and troponin I in pig skin, with additional testing with blood to follow.

Contact Jeb Flemming, Sandia National Laboratories, Albuquerque, NM; 505-844-2230, [email protected],

Suggested Articles

The world’s largest chipmaker saw a 47% decline in data center sales to enterprise and government, even as it forecast a full year 2020 record of $75B

Working with Jacoti of Belgium, Qualcomm wants to make earbuds recognize the hearing anomalies of users.

Tally upgrade from Simbe Robotics uses Nvidia Jetson GPU for edge processing and Intel RealSense LiDAR for higher resolution images